semaj83/ctmatch_classification huggingface dataset:
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 20.0-40.0,  Placenta Accreta Age between 20 years old. 2 Gestational age between 28 weeks. 3 Any patient diagnosed as placenta previa with ultrasound of accretion of accretion by Colour Doppler ultrasound (Berkley et al., 2013). 1. The presence of irregular shaped placental lacunae within the placenta. 2. Thinning of myometrium overlying the placenta. 3. Absence of retroplacental 'non-lucent line'. 4. Protrusion of the placenta into the bladder. 5. Increased vascularity of the uterine serosa-bladder interface. 6. Turbulent blood flow through the lacunae on Doppler ultrasonography
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Endometriosis Adult subjects, aged 18 years old Regular menstrual cycles Endometriosis diagnosed by ultrasonography and gynecological examination, or laparotomy, laparoscopy or imaging analysis (combination of magnetic resonance imaging and ultrasonography) of endometriotic ovarian chocolate cysts The presence of subjective symptoms during menstruation (at least one from among lower abdominal pain, lumbago, defecation pain, nausea and headache The presence of subjective symptoms during non-menstruation (at least one from among lower abdominal pain, lumbago, defecation pain, dyspareunia, and pain on internal examination) The presence of objective findings (induration in the pouch of Douglas and/or limited uterine mobility) Subject is on stable therapy regimen for at least 8 weeks prior to screening period Subjects able and willing to comply with the requirements of the protocol Subjects able to understand and sign written informed consent to participate in the study  Undiagnosed genital bleeding Class 3 or more pap test within 3 months before enrollment Use of GnRH agonist, testosterone derivatives, hormonal therapy with progesterone and/or estrogen, estrogen antagonists or aromatase inhibitors within 16 weeks before enrollment Having undergone surgery therapy or surgical examination for endometriosis within menstrual cycle before the start of medication Use of drugs that could be expected to affect the release of sex hormones (e.g. sulpiride, cimetidine) A history or complication or finding of thrombosis/embolism or depression Malignant tumor complication or finding suggestive of a malignant tumor Complication of serious heart, liver, kidney, blood or endocrine disease Participation in another clinical trial within 4 months before enrollment Patients deemed unsuitable for study entry by the investigator
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 15.0-49.0,  Dysmenorrhea Women within reproductive age (15 to 49 years); 2. Participants who complain about dysmenorrhea with at least grade II level. 3. Self-reported lower abdominal and pelvic, medial anterior thigh pain or low back pain associated with the onset of menses and lasting in 72 hours. 4. Some accompanied symptoms as dizziness and syncope, cramping, nausea, vomiting, diarrhea, headaches, and fatigue present compatible with the menses cycle were also included  Dysmenorrhea resulting from the use of an intra-uterine device (IUD); 2. Mild or infrequent dysmenorrhea. 3. Dysmenorrhea with possible underlying tumor or malignancy
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  ESBL-producing Enterobacteriaceae Infections Age ≥ 18 years Positive sample for ESBL-PE at admission of during ICU stay Patient's or relative's consent  Women pregnant, parturient or breast-feeding during the study period Patient deprived of liberty by judicial or administrative decision Patient undergoing psychiatric care under duress Patient subject to a legal protection measure Patient with no social security coverage
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 0.5-88.0,  Antibiotic Reaction patients with UTI 2. patients with dysuria 3. patients with loin pain  patients with surgery 2. patients with cancer
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Urinary Tract Infections Elderly Infection A clinical diagnosis of UTI according to: pyuria, along with a new complaint of dysuria, urgency or frequency of urination, or lower abdominal pain or discomfort; AND one of the following: systemic fever, flank pain, tenderness over the costo-vertebral angle, rigors and chills, vomiting. 2. Patients with moderate to severe cognitive impairment, who are unable to give reliable anamnesis, or those with permanent indwelling urinary catheter for 24 hours or more, will be considered as suffering from UTI is they present with systemic fever, pyuria and the lack of a more probable infectious cause. 3. Patients who can give informed consent or those with a legal guardian who can consent on their behalf. 4. Patients who received a single dose of any antimicrobial drug prior to recruitment, including amikacin. -  Creatinine clearance < 40 mL/sec according to the Cockcroft-Gault equation 2. A known sensitivity to aminoglycosides 3. A known neuromuscular pathology (including myasthenia gravis). 4. Polycystic kidney disease 5. A urine or blood culture positive for amikacin resistant bacteria in the 30 days prior to recruitment. 6. Clinical suspicion of prostatitis, epididymitis or orchitis. 7. Hemodynamical instability (mean arterial pressure of 65 mmHg or under). 8. More than one dose of antimicrobial treatment that is adequate for classical UTI bacteria, unless a bacterial culture shows resistance to said treatment. 9. Immunosuppressed patients; steroidal treatment will be allowed. -
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Urinary Tract Infections Bladder Cancer Urologic Surgical Procedures Patients 18 years old of age Patients with a programmed TURB Absence of urinary tract infection (negative urine culture and no clinical manifestations for urinary tract infection)  Patients with asymptomatic bacteriuria Patients with positive urine culture before procedure Patients with urinary catheterization
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Bacterial Urinary Tract Infection Patients who have not submitted urine samples will not be included as the samples are required for both standard testing and research. This would patients who are being treated empirically by physicians  Patient's who have not submitted urine samples for culture will not be included in study
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cancer, Colorectal Chemotherapy Effect Weight Loss Prognosis Histologically proven adenocarcinoma of colorectal origin Stage IV disease with systemic treatment Estimated life expectancy >3 months Adequate organ functions  Eastern Cooperative Oncology Group performance status 3 or above Pregnancy Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) Past medical history of another cancer
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Acute Diarrhea Acute Colitis of Presumed Infectious Origin for patients presenting an acute diarrhoea : 1. Patients over 18 years of age, 2. Signed informed consent form 3. Having a social security insurance, 4. Attending the emergency department for Acute diarrhoea (at least three loose or liquid stools a day for less than 15 days) 5. For whom a blood test in the emergency department is ordered as a standard of care for patients presenting an infectious colitis : 1. Patients over 18 years of age, 2. Signed informed consent form 3. Having a social security insurance, 4. Attending the emergency department for a documented colitis presumed to be of infectious origin, for whom a blood test in the emergency department is planned, defined by: 1. at least one of the following symptoms: abdominal pain, fever, diarrhoea and 2. Elevated white blood cell count (> 10.000/mm3) or CRP (> 10 mg/l) and 3. An abdominal CT scan showing a thickening of at least segmental colonic walls  Recent abdominal surgery of less than one month 2. Pregnancy 3. Inflammatory bowel disease 4. Patients under curatorship or guardianship
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Urinary Tract Infections pregnant women who diagnosed through clinical examination and urine analysis. 3 groups : group 1 pregnant women with cystitis Group 2 pregnant women with Pyelonephritis Group 3 pregnant women with asymptomatic bacteriuria  pregnant women on antibiotics _Patients with any anatomical abnormalities in the urinary tract
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 13.0-60.0,  Psoriasis minimum age 13 years maximum age 60 years both males and females affected with mild, moderate and severe psoriasis  hypertension cardiovascular disorders pregnancy lactation renal failure liver failure hypersensitivity to drug
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 20.0-45.0,  Endometriosis Patients confirmed or suspected of endometriosis on clinical evaluation (VAS score more than 5 and presence of subjective symptoms), surgical or imaging studies, and not taking any pain killer or other hormonal treatment for the moment Age 20-45 Regular menstrual cycles The presence of subjective symptoms during menstruation (at least one from among lower abdominal pain, lumbago, defecation pain, nausea, and headache) The presence of subjective symptoms during non-menstruation (at least one from among lower abdominal pain, lumbago, defecation pain, dyspareunia, and pain on internal examination)  Undiagnosed genital bleeding Use of any hormonal therapy for endometriosis within 16 weeks before enrollment A history of severe adverse drug reactions or hypersensitivity to steroid hormone Having undergone surgery therapy or surgical examination for endometriosis within a menstrual cycle before the start of medication Previous failure of treatment with the OCP used in the current study Contraindications to OCP or Dienogest use Smokers >35 A history or complication of thrombosis/embolism Migraines with aura Depression
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Painful Bladder Syndrome Interstitial Cystitis Female and male patients from 18-75 years 2. A history of symptoms of bladder pain/discomfort described as suprapubic pain related to bladder filling, accompanied by other symptoms such as daytime and/or nighttime frequency in the absence of infection or other pathology, with or without the typical cystoscopic findings of interstitial cystitis 3. Patients willing and able to complete the necessary questionnaires  Patients with transitional cell carcinoma of the bladder or other significant malignancy 2. Pregnant women 3. Breastfeading women 4. Patients with significant bacteriuria 5. Patients with hematuria 6. Neurogenic bladder 7. Patients with indwelling catheters 8. Chronic bacterial prostatitis 9. Currently receiving or having received investigational drugs thirty (30) days or less prior to screening 10. Currently receiving or having had prior therapy with intravesical treatment (eg. Uracyst, Cystistat®, heparin or BCG) 11. Receiving therapy for less than three months with antidepressants, antihistaminics, hormonal agonists or antagonists; hence patient not stabilized on therapy. (Stable therapy defined as continuous treatment for at least three months.) 12. IC symptoms relieved by antimicrobials, anticholinergics or antispasmodics 13. Functional Bladder capacity of greater than 400 ml 14. Neurologic disease affecting bladder function; any previous surgery or procedure having affected bladder function 15. Current diagnosis of chemical, tuberculous or radiation cystitis 16. bladder or lower ureteral calculi 17. History of cancer within the last five years other than adequately treated non-melanoma skin cancers 18. Active sexual transmitted disease 19. Current vaginitis 20. Endometriosis 21. Any condition/disease which in the opinion of the investigator could interfere with patient compliance and/ or interfere with the interpretation of the treatment results
Patient description: The patients is a 25-year-old G1 P1 pregnant woman who is 24W3D gestational old who developed a sudden unset of fever and chills, accompany with nausea and vomiting. She also complains of dysuria, urgency and frequency. She also reports some severe pain in the flank. Her vital signs are: T = 39.7ºC, P = 117, R = 20, and BP = 113/74 mm Hg. Physical examination reveals tenderness on palpation of both costovertebral angles. She has no history of recurrent UTI prior to her pregnancy or any other underlying disease. The urine culture showed Gram-negative rod-shaped bacterial cells, leukocytes, and leukocyte casts. The blood culture is negative. A CBC shows Hb 12.9 g/dL, Hct 39%, MCV 76 fL, WBC count 14,120/µL.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Spontaneous Bacterial Peritonitis >18 years of age 2. Cirrhosis with SBP (community acquired, health care associated and nosocomial) and baseline serum bilirubin ≥4 mg/dl or SCr ≥ 1 mg/dl  Antibiotic treatment within one week before the diagnosis of SBP (except for prophylactic treatment with norfloxacin) 2. Significant cardiac failure, pulmonary disease 3. Known CKD ( Chronic Kidney Disease)or findings suggestive of organic nephropathy (proteinuria, haematuria, or Abnormal findings on renal USG) 4. Hepatocellular carcinoma 5. HIV (Human Immunodeficiency Virus) infection; 6. GI (Gastrointestinal) bleed within 1 month before the study 7. Ileus 8. Grade 3 to 4 hepatic encephalopathy 9. Other types of infection 10. Shock 11. Presence of any potential causes of dehydration (such as diarrhoea or an intense response to diuretic treatment) within one week before the diagnosis of SBP). 12. Baseline serum bilirubin <4 mg/dl or S. Cr < 1 mg/dl 13. Serum creatinine level of > 3.0 mg/dl